After the close, Celgene (Nasdaq: CELG) announced that the FDA granted approval of REVLIMID which is indicated for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE